EU half-year report highlights strain of SA and paediatric workload at EMEA
This article was originally published in RAJ Devices
Executive Summary
The half-year report of the European Medicines Agency (EMEA) showed a frenzied amount of activity in the areas of scientific advice (SA), protocol assistance (PA) and paediatric drug assessments. The report, presented at the 60th meeting of the Management Board on 2 October in London, also revealed that the agency’s activities in other areas of human and veterinary medicine appear to be going according to plan.